- Home
- CVGI vs NRXP Comparison
CVGI vs NRXP Comparison
Compare CVGI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- NRXP
- Stock Information
- Founded
- CVGI 2000
- NRXP 2015
- Country
- CVGI United States
- NRXP United States
- Employees
- CVGI N/A
- NRXP N/A
- Industry
- CVGI Auto Parts:O.E.M.
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- CVGI Consumer Discretionary
- NRXP Health Care
- Exchange
- CVGI Nasdaq
- NRXP Nasdaq
- Market Cap
- CVGI 70.3M
- NRXP 58.5M
- IPO Year
- CVGI 2004
- NRXP N/A
- Fundamental
- Price
- CVGI $1.97
- NRXP $2.80
- Analyst Decision
- CVGI
- NRXP Strong Buy
- Analyst Count
- CVGI 0
- NRXP 5
- Target Price
- CVGI N/A
- NRXP $31.40
- AVG Volume (30 Days)
- CVGI 100.2K
- NRXP 533.2K
- Earning Date
- CVGI 11-03-2025
- NRXP 08-18-2025
- Dividend Yield
- CVGI N/A
- NRXP N/A
- EPS Growth
- CVGI N/A
- NRXP N/A
- EPS
- CVGI N/A
- NRXP N/A
- Revenue
- CVGI $676,815,000.00
- NRXP N/A
- Revenue This Year
- CVGI N/A
- NRXP N/A
- Revenue Next Year
- CVGI $7.19
- NRXP $231.16
- P/E Ratio
- CVGI N/A
- NRXP N/A
- Revenue Growth
- CVGI N/A
- NRXP N/A
- 52 Week Low
- CVGI $0.81
- NRXP $1.10
- 52 Week High
- CVGI $3.57
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- CVGI 62.57
- NRXP 51.92
- Support Level
- CVGI $1.76
- NRXP $2.26
- Resistance Level
- CVGI $1.83
- NRXP $3.19
- Average True Range (ATR)
- CVGI 0.09
- NRXP 0.23
- MACD
- CVGI 0.02
- NRXP 0.05
- Stochastic Oscillator
- CVGI 94.44
- NRXP 58.13
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.